Ben Greenfield on health: what the evidence says · JRE #1069
SUBJECT: HEALTH
The short answer
Greenfield claims that while a clinic legally cannot inject a person's own stored stem cells into their bloodstream, it is legal for the person to inject the cells into themselves after the clinic mails the cells to their home. Under U.S. law, FDA regulation of human cell and tissue products (HCT/Ps) turns on characteristics of the product itself, principally whether the cells are minimally manipulated, used for a homologous (allogeneic) function, and not systemically combined with other substances or given a systemic metabolic effect, not on who physically performs the injection.
Not a true/false call. Every claim is logged with its sources; read the exhibits below.
It's technically not legal for someone to inject you with your own stem cells into your bloodstream, but if you get your stem cells extracted and they're stored and they send them to you, you can technically inject them if you do it yourself
What the evidence says 01 / RECORD
Under U.S. law, FDA regulation of human cell and tissue products (HCT/Ps) turns on characteristics of the product itself, principally whether the cells are minimally manipulated, used for a homologous (allogeneic) function, and not systemically combined with other substances or given a systemic metabolic effect, not on who physically performs the injection. Products that are cultured, expanded, stored, or administered systemically for a non-homologous use generally fall outside the low-risk Section 361 exemption and are regulated as biological drugs requiring FDA approval (Section 351) regardless of whether a clinician or the patient administers them. This means the specific mechanism Greenfield describes, that a clinic injecting stored autologous stem cells into the bloodstream is illegal but the same act performed by the patient at home is legal, is not supported by how FDA classification actually works: neither source reviewed identifies who administers the injection as a factor in legal status. Separately, unlicensed or unapproved stem cell injection schemes marketed for regenerative purposes are documented as a category of unproven medical intervention associated with patient harm and financial exploitation, though the reviewed literature does not specifically address self-administration or mail-to-patient arrangements as a described workaround.